The DOI matches its Crossref record; 59 of the 76 references it cites were found in a registry or an index, and 17 are not checked yet.
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients
Abstract
The CD40-CD40L system has pleiotropic effects in a variety of cells and biological processes including immune response, thrombosis and atherogenesis. Within the immune system, these molecules represent a critical link between its humoral and cellular arms. As a result of these attributes and based on preclinical data in animals, anti-CD40L antibodies were tested in a variety of immunologic diseases including idiopathic thrombocytopenic purpura, psoriasis, Crohn's disease, systemic lupus erythematosus and transplantation. Phase I/II studies in humans with lupus nephritis demonstrated reduction of anti-double-stranded DNA (anti-dsDNA) antibodies but not of protective antibodies. Reduction of anti-DNA was associated with increased serum complement levels and reduced glomerular inflammation. As a result of thrombotic effects, observed even in patients negative for anti-cardiolipin antibodies, there is a temporary halt on further human studies. The reasons for the prothrombotic effects are not clear at present but may represent effects on platelets and/or the endothelium. In view of the significant immunomodulatory effects of anti-CD40L treatment in patients with lupus nephritis, the increasing realization of the importance of premature atherosclerosis in lupus and an increasing amount of data supporting a role for the CD40-CD40L interactions in this process, inhibition of this pathway deserves further exploration in lupus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As an example, monoclonal antibodies against CD154, known to cause thromboembolic events in halted clinical trials (Sidiropoulos and Boumpas, 2004), were tested in the VoC model at relevant concentrations and successfully induced thrombosis (Barrile et al., 2018).”
From Considering future qualification for regulatory science in the early development of microphysiological systems: a case study of microthrombosis in a Vessel-on-Chip (2024) · cites this paper as Sidiropoulos and Boumpas, 2004
Citations
Cites
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., MÜLLER‐BERGHAUS, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,082
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
Austin, H. A., Klippel, J. H., Balow, J. E., LeRICHE, N. G. H., Steinberg, A. D., Plötz, P. H., & Decker, J. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603063141004 · Cited by 1,189
Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis
Chan, T. M., Li, F., Tang, C. S.-O., Wong, R. W. S., Fang, G. X., Ji, Y., Lau, C. S., Wong, A. K., Tong, M. K. L., Chan, K. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431604 · Cited by 949
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
Kirk, A. D., Harlan, D. M., Armstrong, N. N., Davis, T. A., Dong, Y., Gray, G. S., Hong, X., Thomas, D. W., Fechner, J. H., & Knechtle, S. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8789 · Cited by 928
Soluble CD40 Ligand in Acute Coronary Syndromes
Heeschen, C., Dimmeler, S., Hamm, C. W., van den Brand, M. J., Boersma, E. H., Zeiher, A. M., & Simoons, M. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022600 · Cited by 827
Boumpas, D. T., Austin, H. A., Balow, J. E., Vaughan, E. M., Yarboro, C. H., Klippel, J. H., & Steinberg, A. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)92292-n · Cited by 820
Self-citationMach, F., Schönbeck, U., Sukhova, G. K., Bourcier, T., Bonnefoy, J., Pober, J. S., & Libby, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1931 · Cited by 730
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
André, P., Prasad, K. S. S., Denis, C. V., He, M.-S., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 725
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
Kawai, T., Andrews, D. M., Colvin, R. B., Sachs, D. H., & Cosimi, A. B. (2000) · Nature Medicine · doi:10.1038/72162 · Cited by 693
Research works printed but not linked: 5
- Bussel JB., 2000, Semin Oncol, 27, 91
- Balow JE, 2000, Semin Nephrol, 20, 32
- Davis JC Jr, 2001, J Rheumatol, 28, 95
- Dumont FJ., 2002, Curr Opin Invest Drugs, 3, 725
- 10.1038/ki.1997.102 · DOI
Cited by
Sorted by citations
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,663
Advances in graft-versus-host disease biology and therapy
Blazar, B. R., Murphy, W. J., & Abedi, M. (2012) · Nature reviews. Immunology · doi:10.1038/nri3212 · Cited by 900
B-cell targeting in rheumatoid arthritis and other autoimmune diseases
Edwards, J., & Cambridge, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1838 · Cited by 507
B CELL IMMUNOBIOLOGY IN DISEASE: Evolving Concepts from the Clinic
Martin, F., & Chan, A. C. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090517 · Cited by 372
Pathogenesis of human systemic lupus erythematosus: recent advances
Crispín, J. C., Liossis, S. C., Kis‐Tóth, K., Lieberman, L. A., Kyttaris, V. C., Juang, Y., & Tsokos, G. C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.12.005 · Cited by 367
Metadata
- Authors
- Sidiropoulos, P. I., & Boumpas, D. T.
- Affiliations
- University of Crete (GR)
- Corresponding author
- Boumpas, D T
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2004-05
- Volume
- 13
- Issue
- 5
- Pages
- 391-397
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W2074674463
- Cited by
- 178
- References
- 75
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 14 · 2018: 10 · 2017: 8 · 2016: 7 · 2015: 18 · 2014: 11 · 2013: 8 · 2012: 14
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- anti-CD40L antibody, CD40-CD40L interaction, systemic lupus erythematosus, lupus nephritis, anti-dsDNA antibodies, complement system, thrombosis, atherosclerosis, platelets, endothelium, immunomodulation, anticardiolipin antibodies
- MeSH terms
- Antibodies, Monoclonal, Antibody Formation, B-Lymphocytes, Humans, Immunotherapy, Lupus Erythematosus, Systemic, CD40 Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
